Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Potential Nephroprotective Effects of Resveratrol in Drug Induced Nephrotoxicity: A Narrative Review of Safety and Efficacy Data Publisher



Shahbazi F1, 2 ; Farvadi F3 ; Dashtikhavidaki S4 ; Ataei S5 ; Shojaei L1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Pharmacy, Faculty of Pharmacy, Kermanshah University of Medical Sciences, P.O.Box: 67145-1673, Kermanshah, 6734667149, Iran
  2. 2. Pharmaceutical Sciences Research Center, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
  3. 3. Department of Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Liver Transplantation Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran

Source: Advances in Traditional Medicine Published:2020


Abstract

Drug induced nephrotoxicity commonly occurs in hospitalized patients and sometimes may complicate treatment outcome, especially in critically ill patients. No universal prophylactic agent is available yet to protect against drug related nephrotoxicity. Many modalities have been applied with different successes. Polyphenolic compounds such as resveratrol have been used both in-vitro and in vivo to prevent drug induced nephrotoxicity. Resveratrol have several antioxidant, antiplatelet and nitric oxide releasing properties in preclinical studies. In this review, we discuss recent studies that evaluated resveratrol protective effects, the mechanism of action and safety issues on drug induced nephrotoxicity. © 2020, Institute of Korean Medicine, Kyung Hee University.
Other Related Docs
9. Resveratrol: More Than a Phytochemical, Biomedical Reviews (2015)
19. Challenges in the Delivery of Polyphenols to Cancer Cells, Mitochondrial Dysfunction and Nanotherapeutics: Aging# Diseases# and Nanotechnology-Related Strategies in Mitochondrial Medicine (2021)